![](https://investorshub.advfn.com/uicon/374204.png?cb=1652542310)
Friday, April 08, 2022 2:05:06 PM
Apr. 08, 2022 9:43 AM ETBioNTech SE (BNTX)By: Ravikash, SA News Editor
BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine
Thomas Lohnes/Getty Images News
BioNTech (NASDAQ:BNTX) said it is one of the companies in Germany to be granted a pandemic preparedness contract by the Germany Federal Ministry of Health.
The company said the framework agreement is aimed at pandemic preparedness including manufacturing and supply of mRNA vaccines in emergency situations in Germany.
Under the agreement, BioNTech will reserve and maintain manufacturing capabilities to produce at least 80M mRNA-based vaccine doses per year.
The contract has an initial term of five years.
"There is growing evidence that viral pandemics will continue to pose a public health challenge for years. This contract with the German government will ensure significant supply of vaccine doses to address potential public health threats by 2027,” said BioNTech's Chief Business and Chief Commercial Officer.
BioNTech gets contract from Germany for mRNA vaccines for pandemic response
Apr. 08, 2022 9:43 AM ETBioNTech SE (BNTX)By: Ravikash, SA News Editor
BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine
Thomas Lohnes/Getty Images News
BioNTech (NASDAQ:BNTX) said it is one of the companies in Germany to be granted a pandemic preparedness contract by the Germany Federal Ministry of Health.
The company said the framework agreement is aimed at pandemic preparedness including manufacturing and supply of mRNA vaccines in emergency situations in Germany.
Under the agreement, BioNTech will reserve and maintain manufacturing capabilities to produce at least 80M mRNA-based vaccine doses per year.
The contract has an initial term of five years.
"There is growing evidence that viral pandemics will continue to pose a public health challenge for years. This contract with the German government will ensure significant supply of vaccine doses to address potential public health threats by 2027,” said BioNTech's Chief Business and Chief Commercial Officer.
Awesome News imo
![wink](/images/emoticon03.gif)
BNTX $$$$
Recent BNTX News
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union • Business Wire • 06/27/2024 02:30:00 PM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union • GlobeNewswire Inc. • 06/27/2024 02:30:00 PM
- BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer • GlobeNewswire Inc. • 06/24/2024 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2024 11:18:30 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/03/2024 11:46:32 AM
- Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) • GlobeNewswire Inc. • 06/01/2024 02:00:00 PM
- Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) • Business Wire • 06/01/2024 02:00:00 PM
- BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership • PR Newswire (US) • 05/27/2024 12:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/21/2024 08:36:58 PM
- BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024 • GlobeNewswire Inc. • 05/21/2024 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/17/2024 08:10:43 PM
- BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 • GlobeNewswire Inc. • 05/17/2024 03:15:00 PM
- Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise • IH Market News • 05/06/2024 12:09:15 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/06/2024 11:18:26 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/06/2024 10:48:54 AM
- BioNTech Announces First Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 05/06/2024 10:45:00 AM
- Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News • IH Market News • 04/26/2024 11:48:07 AM
- Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News • IH Market News • 04/24/2024 11:28:02 AM
- BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 • GlobeNewswire Inc. • 04/22/2024 10:45:00 AM
- Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer • GlobeNewswire Inc. • 04/07/2024 06:00:00 PM
- Apple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market Updates • IH Market News • 03/21/2024 11:17:26 AM
- U.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices Dip • IH Market News • 03/20/2024 11:17:32 AM
- BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update • GlobeNewswire Inc. • 03/20/2024 10:15:00 AM
- BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer • GlobeNewswire Inc. • 03/20/2024 10:00:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM